KEAP1 and neoplasm: Additionally, Zavitsanou et al. generated an antigenic lung cancer mouse model and showed that tumours harbouring KEAP1 mutations accelerated tumour growth and decreased dendritic cell and T cell responses, which promoted resistance to immunotherapy.